Galderma Group AG (GALDY)
OTCMKTS · Delayed Price · Currency is USD
24.33
+0.90 (3.84%)
May 9, 2025, 4:00 PM EDT
46.13%
Market Cap 28.28B
Revenue (ttm) 4.44B
Net Income (ttm) 231.00M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 122.40
Forward PE 40.14
Dividend 0.02 (0.10%)
Ex-Dividend Date Apr 28, 2025
Volume 5,163
Average Volume 6,526
Open 23.64
Previous Close 23.43
Day's Range 23.64 - 24.88
52-Week Range 15.51 - 27.20
Beta n/a
RSI 67.54
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GALDY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.